These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 10206542)
1. One-pot synthesis of 2-substituted 4H-3,1-benzoxazin-4-one derivatives under mild conditions using iminium cation from cyanuric chloride/dimethylformamide as a cyclizing agent. Shariat M; Samsudin MW; Zakaria Z Chem Cent J; 2013 Mar; 7(1):58. PubMed ID: 23537478 [TBL] [Abstract][Full Text] [Related]
2. Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G. Aliter KF; Al-Horani RA Med Chem; 2024 Apr; ():. PubMed ID: 38676528 [TBL] [Abstract][Full Text] [Related]
3. Silica-bound benzoyl chloride mediated the solid-phase synthesis of 4H-3,1-benzoxazin-4-ones. Rad-Moghadam K; Rouhi S Beilstein J Org Chem; 2009 Apr; 5():13. PubMed ID: 19478965 [TBL] [Abstract][Full Text] [Related]
4. Iodine-mediated oxythiolation of Yang Y; Liu L; Li K; Zha Z; Sun Q; Wang Z RSC Adv; 2022 Mar; 12(12):7347-7351. PubMed ID: 35424675 [TBL] [Abstract][Full Text] [Related]
5. Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing. Pereira MJ; Wager B; Garrigues RJ; Gerlach E; Quinn JD; Dowdell AS; Osburne MS; Zückert WR; Kraiczy P; Garcia BL; Leong JM Proc Natl Acad Sci U S A; 2022 Mar; 119(13):e2117770119. PubMed ID: 35312359 [TBL] [Abstract][Full Text] [Related]
6. Targeting the Initiator Protease of the Classical Pathway of Complement Using Fragment-Based Drug Discovery. Rushing BR; Rohlik DL; Roy S; Skaff DA; Garcia BL Molecules; 2020 Sep; 25(17):. PubMed ID: 32899120 [TBL] [Abstract][Full Text] [Related]
7. Structure-based virtual screening of small-molecule antagonists of platelet integrin αIIbβ3 that do not prime the receptor to bind ligand. Negri A; Li J; Naini S; Coller BS; Filizola M J Comput Aided Mol Des; 2012 Sep; 26(9):1005-15. PubMed ID: 22893377 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease. Barnum SR Mol Med; 1999 Sep; 5(9):569-82. PubMed ID: 10551898 [No Abstract] [Full Text] [Related]
10. The structure and function of the first component of complement: genetic engineering approach (a review). Gál P; Cseh S; Schumaker VN; Závodszky P Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721 [TBL] [Abstract][Full Text] [Related]